Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Across Protocol (ACX) vs Immunefi (IMU) Price & Performance

Across Protocol Trade

Price performance (Past 24H)

Key statistics

Across Protocol vs Immunefi — how do they compare? Across Protocol trades at Rp739.03 (market cap Rp505,3M, Rp188,8M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Across Protocol is far larger — about 18.7× Immunefi's market cap, and Across Protocol 's circulating supply is 716,5M / 1B ACX (72%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 57 Days and Immunefi for 5 Days on average.

ACXIMU
Market Cap
Rp505,3MRp27,03M
Volume (24h)
Rp188,8MRp39,91M
Circulating Supply
716,5M / 1B ACX (72%)873,4M / 10B IMU (9%)
Typical Hold Time
57 Days5 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Across Protocol

Across Protocol (ACX) is trading at Rp728.43 with a market cap of Rp505.3M, showing bearish technical signals with 15 sell signals versus 3 buys. The token is near its pivot point of Rp714, with key support at Rp665 and resistance at Rp751. With 72% of max supply in circulation and average hold time of 57 days, the token shows moderate distribution. No major protocol updates or ecosystem developments have been reported recently.

Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in oversold RSI conditions suggesting potential bounce, while major risks include low liquidity and concentrated sell pressure. Investors should monitor support levels closely and watch for any protocol developments that could shift momentum.

Immunefi

IMU token shows limited market activity with a modest market cap of Rp27.03M and only 9% circulating supply. The token exhibits low trading volume and minimal network activity, with a short average hold time of 5 days indicating speculative trading patterns. Recent coverage appears to confuse this cryptocurrency with a corporate entity, creating market confusion.

Outlook remains cautious due to extremely low liquidity and market confusion with traditional equity. Key risk is entity misidentification impacting proper valuation. Opportunity exists if protocol utility develops, but current fundamentals are weak with minimal ecosystem activity.

About Across Protocol

Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.

Read more on ACX

About Immunefi

Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.

Read more on IMU